|
S3-Blastocyst
Vitrification
Introducing a
new method for storing human blastocysts: S3
- Vitrification
This novel, successful method was
developed by cryobiologist James Stachecki, Ph.D. in conjunction with Steen
Willadsen, Ph.D., D.V.M. and Jacques Cohen, Ph.D. at Tyho-Galileo Research
Laboratories. We call it “S3-Vitrification”. We believe that
this new method is safer and simpler than existing vitrification methods.
We also believe that it will be highly successful.
Major features of the
S3-Vitrification
technology:
Ø
Secure:
Blastocysts are frozen in heat-sealed 0.25cc conventional freezing
straws.
We do not use an open container like a
cryo-loop, open-pulled straw, hemi-straw, or microscope grid, so there is less
chance of viral or other contamination. The use of open-containers may be
prohibited. That’s why we looked into adapting the method to use conventional
straws that many clinics are already familiar with. The straws can be heat
sealed at both ends providing a safe and secure environment. Additionally,
unlike many other vitrification methods available, our method does not use DMSO,
one of the more potentially damaging cryoprotectants.
Ø
Simple:
The technique is easy to learn and use.
Since we use conventional freezing straws there
are no tiny cryo-loops, micro-sized straws, or microscope grids to fuss with.
Additionally, the technique allows for plenty of time to load and seal the straw
before cooling. It is mandatory in many protocols to start cooling within 30
seconds of contact with the final vitrification solution or embryo survival
rates rapidly decrease! This is technically challenging and, more importantly,
leaves no room for technician error. We all make mistakes, so why not use a
protocol that allows enough time to load (up to three times as long) and cool
the sample without jeopardizing survival rates.
Ø
Successful:
In laboratory studies we have obtained over 90% survival of human and
bovine blastocysts (including 90-100% re-expansion rates, and 90-100% survival
of individual blastomeres within each embryo).
You can use any stage blastocyst from cavitating
to fully-expanded, or even hatched blastocysts. No artificial shrinkage or
collapsing of the blastocoel is required! Data from collaborating clinics are
promising. IRMS, West Orange, NJ initially reported a survival rate over 90%,
and a pregnancy rate over 60%. Several clinics have now switched from
slow-cooling using glycerol to S3-vitrification.
As
more and more clinics convert to blastocyst transfer to reduce multiple
pregnancies, a safe, efficient, and reproducible method for storing
blastocysts will be needed. The S3-vitrification technology
fills this need. The major advantages of this technology over existing
techniques are readily apparent, as outlined above. Please contact us for
more information about this new method of storing blastocysts or to become a
licensed clinic and start providing this option to your patients today.
For more information please email us at: S3@galileoivf.com.
HOME
| ABOUT US |
RESEARCH |
CONSULTING | MEMBERSHIP |
LINKS |
CONTACT US
|